Infants who show defective immune responses to microbial components are more likely to acquire asthma later...
Up To Date
Latest News
MaaT Pharma SA has announced €18m Series B financing to boost its microbiome biotherapeutics pipeline.
French vaccine developer Valneva SA will raise $85m in a financing arrangement with Deerfield and OrbiMed and...
Researchers at the University of Luebeck have revealed the structure of the IMP dehydrogenase, a central...
Scientists at Imperial College London have created a worldwide atlas of dengue virus transmission with much...
Share
